Delivery Order SPE2DB20D3101-SPE2DB25FRMA3
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Ropivacaine 0.2% in a 400 mg/200 ml dosage format. This firm fixed-price delivery order, valued at $2,818.62, represents a non-competitive set-aside procurement and is scheduled for completion by June 20, 2025, with performance taking place at the vendor's facility in Conshohocken, Pennsylvania. The award is issued as a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Ropivacaine 0.2% 400 mg/200 ml in 200 ml quantities, with a firm fixed price ceiling value of $1,908.72. The contract, which is a non-set-aside competitive award with an ultimate completion date of June 6, 2025, is performed from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL) with a ceiling value of $3,342.70 and an ultimate completion date of July 1, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a total value of $999,999,999.00 and extends through...
- The Defense Logistics Agency awarded a $4,400.42 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL), a local anesthetic pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL) in 200 mL quantities, with a contract ceiling value of $3,419.59. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open procurement channels. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency awarded a $2,477.82 delivery order to AmerisourceBergen Drug Corp on June 11, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 ml), a local anesthetic pharmaceutical product. This firm fixed price contract, with an ultimate completion date of June 12, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation, and performance will...
- The Defense Logistics Agency awarded a delivery order valued at $3,428.19 to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 ml in 200 ml units). This firm fixed-price delivery order is scheduled for completion by June 20, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award was made on a competitive basis with no set-aside designation, reflecting the vendor's established capability to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of Ropivacaine 0.2% 200 mg/100 mL, a local anesthetic medication, with a ceiling value of $1,029.75 and an ultimate completion date of August 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to...
- The Defense Logistics Agency awarded a $2,345.08 delivery order to AmerisourceBergen Drug Corp on May 22, 2025, for the supply of Ropivacaine 0.2% 400 mg/200 mL in 200 mL quantities, with completion targeted for May 23, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, utilizing open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,410.92 to AmerisourceBergen Drug Corp for the supply of Ropivacaine 0.2% (400 mg/200 ml, 200 ml units) with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRMA3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,558.46 to AmerisourceBergen Drug Corp for Ropivacaine 0.2% (400 mg/200 mL), a local anesthetic medication commonly used in medical and surgical procedures. The contract was awarded on June 2, 2025, with an ultimate completion date of June 3, 2025, under a firm fixed-price arrangement with no set-aside designation. Performance will occur at the vendor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal healthcare needs, particularly military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The vendor's federal contract portfolio demonstrates extensive experience fulfilling competitively awarded delivery orders for a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains. All reviewed contract awards, including this Ropivacaine procurement, were non-set-aside and competitively awarded, reflecting the company's demonstrated capability to meet federal procurement requirements and support military medical operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 6/2/25 |